You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

https://doi.org/10.1136/jitc-2020-001694corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Mandala M, Lorigan P, De Luca M, et al. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. J Immunother Cancer 2021;9:e001694. doi: 10.1136/jitc-2020-001694

    This article has been corrected since it first published. The provenance and peer review statement has been added.